KEGG   PATHWAY: ssc04310
Entry
ssc04310                    Pathway                                
Name
Wnt signaling pathway - Sus scrofa (pig)
Description
Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.
Class
Environmental Information Processing; Signal transduction
Pathway map
ssc04310  Wnt signaling pathway
ssc04310

Other DBs
GO: 0016055
Organism
Sus scrofa (pig) [GN:ssc]
Gene
100627921  PORCN; protein-serine O-palmitoleoyltransferase porcupine isoform X4 [KO:K00181] [EC:2.3.1.250]
100525462  WNT1; proto-oncogene Wnt-1 [KO:K03209]
100516839  WNT2; protein Wnt-2 [KO:K00182]
100520560  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
100514950  WNT3A; protein Wnt-3a isoform X1 [KO:K00312]
100519512  WNT3; proto-oncogene Wnt-3 isoform X1 [KO:K00312]
100327037  WNT4; protein Wnt-4 [KO:K00408]
100516268  WNT5B; LOW QUALITY PROTEIN: protein Wnt-5b [KO:K00444]
100627056  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
100622044  WNT6; protein Wnt-6 [KO:K00445]
100153445  WNT7A; protein Wnt-7a [KO:K00572]
100626947  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
100513655  WNT8B; protein Wnt-8b isoform X1 [KO:K00714]
100739710  WNT8A; protein Wnt-8a [KO:K00714]
100512949  WNT9A; protein Wnt-9a [KO:K01064]
100738655  WNT9B; protein Wnt-9b [KO:K01064]
100126276  WNT10B; protein Wnt-10b precursor [KO:K01357]
100623646  WNT10A; LOW QUALITY PROTEIN: protein Wnt-10a [KO:K01357]
100521912  WNT11; protein Wnt-11 [KO:K01384]
100511484  WNT16; protein Wnt-16 [KO:K01558]
110255508  CER1; cerberus [KO:K01645]
110255930  NOTUM; palmitoleoyl-protein carboxylesterase NOTUM [KO:K19882] [EC:3.1.1.98]
100512657  WIF1; wnt inhibitory factor 1 precursor [KO:K01691]
100513306  SOST; sclerostin [KO:K16834]
100157640  DKK1; dickkopf-related protein 1 precursor [KO:K02165]
100519672  DKK2; dickkopf-related protein 2 [KO:K02165]
106508176  DKK4; dickkopf-related protein 4 [KO:K02165]
780402  SERPINF1; pigment epithelium-derived factor precursor [KO:K19614]
100621622  SFRP1; secreted frizzled-related protein 1 [KO:K02166]
100516027  SFRP2; secreted frizzled-related protein 2 precursor [KO:K02176]
100152419  FRZB; secreted frizzled-related protein 3 precursor [KO:K25481]
100145890  SFRP4; secreted frizzled-related protein 4 precursor [KO:K02185]
100153176  SFRP5; secreted frizzled-related protein 5 precursor [KO:K02222]
100622113  RSPO1; R-spondin-1 [KO:K19471]
100154008  RSPO2; R-spondin-2 precursor [KO:K23097]
100155208  RSPO3; R-spondin-3 precursor [KO:K23098]
100518279  RSPO4; R-spondin-4 [KO:K23099]
100518646  LGR4; leucine-rich repeat-containing G-protein coupled receptor 4 isoform X2 [KO:K04309]
100151994  LGR5; leucine-rich repeat-containing G-protein coupled receptor 5 precursor [KO:K04308]
100511400  LGR6; leucine-rich repeat-containing G-protein coupled receptor 6 isoform X1 [KO:K08399]
100517305  RNF43; LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase RNF43 [KO:K15694] [EC:2.3.2.27]
100153654  ZNRF3; E3 ubiquitin-protein ligase ZNRF3 isoform X1 [KO:K16273] [EC:2.3.2.27]
100513691  FZD7; frizzled-7 [KO:K02432]
110262227  FZD1; frizzled-1 [KO:K02432]
100337669  FZD2; frizzled-2 precursor [KO:K02235]
100153078  FZD3; frizzled-3 isoform X1 [KO:K02329]
100520319  FZD4; LOW QUALITY PROTEIN: frizzled-4 [KO:K02354]
100519058  FZD5; frizzled-5 [KO:K02375]
110255708  FZD8; LOW QUALITY PROTEIN: frizzled-8 [KO:K02375]
100157360  FZD6; frizzled-6 precursor [KO:K02376]
100511782  FZD10; frizzled-10 [KO:K02842]
100625784  FZD9; frizzled-9 [KO:K02842]
100515777  LRP6; LOW QUALITY PROTEIN: low-density lipoprotein receptor-related protein 6 [KO:K03068]
100524299  LRP5; low-density lipoprotein receptor-related protein 5 isoform X1 [KO:K03068]
449001  BAMBI; BMP and activin membrane-bound inhibitor homolog precursor [KO:K10162]
100626308  APCDD1; protein APCDD1 [KO:K25812]
100151808  APCDD1L; protein APCDD1-like [KO:K25812]
100523244  casein kinase I isoform X2 [KO:K08960] [EC:2.7.11.1]
100152429  CCDC88C; protein Daple [KO:K25811]
100525170  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X2 [KO:K02353]
100621038  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
100625452  DVL2; LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
110256598  FRAT1; proto-oncogene FRAT1 [KO:K03069]
110256599  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
100517435  CSNK2A1; casein kinase II subunit alpha [KO:K03097] [EC:2.7.11.1]
100737256  CSNK2A2; casein kinase II subunit alpha' isoform X1 [KO:K03097] [EC:2.7.11.1]
397211  CSNK2B; casein kinase II subunit beta [KO:K03115]
100626194  NKD1; protein naked cuticle homolog 1 isoform X1 [KO:K03213]
110257348  NKD2; LOW QUALITY PROTEIN: protein naked cuticle homolog 2 [KO:K03213]
100521810  CXXC4; CXXC-type zinc finger protein 4 [KO:K03344]
100738022  SENP2; sentrin-specific protease 2 isoform X1 [KO:K03345] [EC:3.4.22.68]
100126852  GSK3B; glycogen synthase kinase-3 beta [KO:K03083] [EC:2.7.11.26]
397657  CTNNB1; catenin beta-1 [KO:K02105]
100523725  AXIN1; axin-1 isoform X1 [KO:K02157]
100739604  AXIN2; axin-2 isoform X1 [KO:K04385]
100517932  APC; adenomatous polyposis coli protein [KO:K02085]
100579172  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
100514516  CSNK1A1; casein kinase I isoform X4 [KO:K08957] [EC:2.7.11.1]
100512951  TCF7; transcription factor 7 isoform X1 [KO:K02620]
100523899  TCF7L1; LOW QUALITY PROTEIN: transcription factor 7-like 1 [KO:K04490]
100153922  TCF7L2; transcription factor 7-like 2 isoform X26 [KO:K04491]
100170126  LEF1; lymphoid enhancer-binding factor 1 [KO:K04492]
100625806  LZTS2; leucine zipper putative tumor suppressor 2 isoform X1 [KO:K26471]
100627651  CTNNBIP1; beta-catenin-interacting protein 1 isoform X1 [KO:K04493]
100144768  CBY1; protein chibby homolog 1 [KO:K23402]
100156733  CHD8; chromodomain-helicase-DNA-binding protein 8 isoform X3 [KO:K04494] [EC:5.6.2.-]
100515712  MCC; colorectal mutant cancer protein isoform X1 [KO:K26734]
100155718  CCAR2; cell cycle and apoptosis regulator protein 2 [KO:K25816]
751859  SIRT1; NAD-dependent protein deacetylase sirtuin-1 [KO:K11411] [EC:2.3.1.286]
100154087  SOX17; transcription factor SOX-17 [KO:K04495]
100154421  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
110262035  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
100513797  transducin-like enhancer protein 2 [KO:K04497]
100622728  TLE2; transducin-like enhancer protein 2 isoform X3 [KO:K04497]
100154048  TLE3; transducin-like enhancer protein 3 isoform X1 [KO:K04497]
100156044  TLE4; transducin-like enhancer protein 4 isoform X2 [KO:K04497]
100524475  transducin-like enhancer protein 1 isoform X3 [KO:K04497]
100623564  TLE6; transducin-like enhancer protein 6 isoform X1 [KO:K04497]
100517978  CTNND2; catenin delta-2 isoform X1 [KO:K23491]
100156226  EP300; LOW QUALITY PROTEIN: histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
100620215  CREBBP; CREB-binding protein [KO:K04498] [EC:2.3.1.48]
100518219  RUVBL1; ruvB-like 1 isoform X1 [KO:K04499] [EC:5.6.2.4]
397142  SMAD4; mothers against decapentaplegic homolog 4 [KO:K04501]
397260  SMAD3; mothers against decapentaplegic homolog 3 [KO:K23605]
100135663  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
100511657  NLK; serine/threonine-protein kinase NLK [KO:K04468] [EC:2.7.11.24]
448810  MYC; myc proto-oncogene protein [KO:K04377]
396913  JUN; transcription factor AP-1 [KO:K04448]
100525205  FOSL1; fos-related antigen 1 [KO:K04502]
100738589  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
397162  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
780426  CCND3; G1/S-specific cyclin-D3 [KO:K10152]
100739115  WISP1; WNT1-inducible-signaling pathway protein 1 isoform X1 [KO:K22471]
397297  PPARD; peroxisome proliferator-activated receptor delta [KO:K04504]
397411  MMP7; matrilysin [KO:K01397] [EC:3.4.24.23]
780411  PSEN1; presenilin-1 [KO:K04505] [EC:3.4.23.-]
397652  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
100623628  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
397276  TP53; cellular tumor antigen p53 [KO:K04451]
100520614  SIAH1; E3 ubiquitin-protein ligase SIAH1 isoform X1 [KO:K04506] [EC:2.3.2.27]
100519266  CACYBP; calcyclin-binding protein isoform X1 [KO:K04507]
100520183  LOW QUALITY PROTEIN: S-phase kinase-associated protein 1 [KO:K03094]
110259483  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
100522831  TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1 isoform X1 [KO:K04508]
100624648  F-box-like/WD repeat-containing protein TBL1X isoform X2 [KO:K04508]
102166569  TBL1X; F-box-like/WD repeat-containing protein TBL1X isoform X1 [KO:K04508]
100157842  BTRC; F-box/WD repeat-containing protein 1A isoform X5 [KO:K03362]
100523218  FBXW11; F-box/WD repeat-containing protein 11 isoform X1 [KO:K03362]
100524037  CUL1; cullin-1 [KO:K03347]
110260638  RBX1; E3 ubiquitin-protein ligase RBX1 isoform X1 [KO:K03868] [EC:2.3.2.32]
100156029  GPC4; glypican-4 [KO:K08110]
100520620  ROR1; inactive tyrosine-protein kinase transmembrane receptor ROR1 isoform X1 [KO:K05122] [EC:2.7.10.1]
100154208  ROR2; tyrosine-protein kinase transmembrane receptor ROR2 [KO:K05123] [EC:2.7.10.1]
100523513  RYK; LOW QUALITY PROTEIN: tyrosine-protein kinase RYK [KO:K05128] [EC:2.7.10.1]
100157791  VANGL1; vang-like protein 1 [KO:K04510]
100158100  VANGL2; vang-like protein 2 [KO:K04510]
100157209  PRICKLE1; prickle-like protein 1 isoform X1 [KO:K04511]
100520050  PRICKLE2; prickle-like protein 2 isoform X3 [KO:K04511]
100520848  PRICKLE4; prickle-like protein 4 [KO:K04511]
100512323  PRICKLE3; prickle-like protein 3 [KO:K04511]
100155489  INVS; inversin isoform X5 [KO:K19626]
100517445  DAAM1; disheveled-associated activator of morphogenesis 1 isoform X1 [KO:K04512]
100155713  DAAM2; LOW QUALITY PROTEIN: disheveled-associated activator of morphogenesis 2 [KO:K04512]
396849  RHOA; transforming protein RhoA [KO:K04513]
397445  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
100627149  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
100621675  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
110255928  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
396610  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
100521736  MAPK10; mitogen-activated protein kinase 10 isoform X3 [KO:K04440] [EC:2.7.11.24]
396609  MAPK9; mitogen-activated protein kinase 9 isoform X4 [KO:K04440] [EC:2.7.11.24]
100152679  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
100157641  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
100516581  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
100525148  PLCB3; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
397674  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta [KO:K04515] [EC:2.7.11.17]
397394  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma [KO:K04515] [EC:2.7.11.17]
100626014  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X7 [KO:K04515] [EC:2.7.11.17]
100516166  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
397241  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [KO:K04348] [EC:3.1.3.16]
100158082  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X4 [KO:K04348] [EC:3.1.3.16]
396603  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X3 [KO:K04348] [EC:3.1.3.16]
100625117  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
100627903  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
397184  PRKCA; LOW QUALITY PROTEIN: protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
100522792  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
100518074  PRKCG; protein kinase C gamma type isoform X3 [KO:K19663] [EC:2.7.11.13]
397318  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446]
100134969  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 [KO:K17332]
100739450  NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333]
100154469  NFATC4; nuclear factor of activated T-cells, cytoplasmic 4 isoform X1 [KO:K17334]
Compound
C00076  Calcium cation
Reference
  Authors
Hatsell S, Rowlands T, Hiremath M, Cowin P.
  Title
Beta-catenin and Tcfs in mammary development and cancer.
  Journal
J Mammary Gland Biol Neoplasia 8:145-58 (2003)
DOI:10.1023/A:1025944723047
Reference
  Authors
Yang Y.
  Title
Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.
  Journal
Birth Defects Res Part C Embryo Today 69:305-17 (2003)
DOI:10.1002/bdrc.10026
Reference
  Authors
Kalderon D.
  Title
Similarities between the Hedgehog and Wnt signaling pathways.
  Journal
Trends Cell Biol 12:523-31 (2002)
DOI:10.1016/S0962-8924(02)02388-7
Reference
  Authors
Nusse R.
  Title
Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.
  Journal
Development 130:5297-305 (2003)
DOI:10.1242/dev.00821
Reference
  Authors
Jope RS, Johnson GV.
  Title
The glamour and gloom of glycogen synthase kinase-3.
  Journal
Trends Biochem Sci 29:95-102 (2004)
DOI:10.1016/j.tibs.2003.12.004
Reference
  Authors
Veeman MT, Axelrod JD, Moon RT.
  Title
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
  Journal
Dev Cell 5:367-77 (2003)
DOI:10.1016/S1534-5807(03)00266-1
Reference
  Authors
Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.
  Title
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.
  Journal
Nat Cell Biol 3:628-36 (2001)
DOI:10.1038/35083016
Reference
  Authors
Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E
  Title
The way Wnt works: Components and mechanism.
  Journal
Growth Factors 31:1-31 (2013)
DOI:10.3109/08977194.2012.752737
Reference
  Authors
Carethers JM
  Title
Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.
  Journal
Gastroenterology 137:33-6 (2009)
DOI:10.1053/j.gastro.2009.05.011
Reference
  Authors
Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG
  Title
The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.
  Journal
J Biol Chem 283:33053-8 (2008)
DOI:10.1074/jbc.M804039200
Reference
  Authors
Niehrs C
  Title
The complex world of WNT receptor signalling.
  Journal
Nat Rev Mol Cell Biol 13:767-79 (2012)
DOI:10.1038/nrm3470
Reference
  Authors
Abou Ziki MD, Mani A
  Title
Wnt signaling, a novel pathway regulating blood pressure? State of the art review.
  Journal
Atherosclerosis 262:171-178 (2017)
DOI:10.1016/j.atherosclerosis.2017.05.001
Reference
  Authors
He Y, Ki H, Kim H, Kim K
  Title
delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.
  Journal
Cell Biol Int 39:954-61 (2015)
DOI:10.1002/cbin.10465
Reference
  Authors
Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S, Takahashi M
  Title
The Daple-CK1epsilon complex regulates Dvl2 phosphorylation and canonical Wnt signaling.
  Journal
Biochem Biophys Res Commun 532:406-413 (2020)
DOI:10.1016/j.bbrc.2020.08.066
Reference
  Authors
Yiew NKH, Chatterjee TK, Tang YL, Pellenberg R, Stansfield BK, Bagi Z, Fulton DJ, Stepp DW, Chen W, Patel V, Kamath VM, Litwin SE, Hui DY, Rudich SM, Kim HW, Weintraub NL
  Title
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.
  Journal
J Biol Chem 292:6312-6324 (2017)
DOI:10.1074/jbc.M116.758078
Related
pathway
ssc04010  MAPK signaling pathway
ssc04110  Cell cycle
ssc04115  p53 signaling pathway
ssc04120  Ubiquitin mediated proteolysis
ssc04350  TGF-beta signaling pathway
ssc04510  Focal adhesion
ssc04520  Adherens junction
ssc05010  Alzheimer disease
KO pathway
ko04310   
LinkDB

DBGET integrated database retrieval system